When an IVF cycle produces more embryos than are transferred in the initial attempt — which happens in many well-managed cycles — the question that immediately arises is what to do with the ones that were not used. For most couples and in most clinical circumstances, the answer is to freeze them.
Embryo freezing — cryopreservation — and the frozen embryo transfer cycle that follows when those embryos are eventually used are among the most important developments in modern IVF practice. They have changed what a single IVF stimulation cycle can achieve, they have improved overall IVF success rates, and they have fundamentally altered the clinical strategy around IVF in ways that benefit a wide range of patients.
Yet despite the centrality of embryo freezing to modern IVF practice, many couples who undergo IVF receive only a brief explanation of what it means and why it matters. This article provides the complete explanation — what embryo freezing is, how the technology works, who benefits from it, what a frozen embryo transfer cycle involves, and what the clinical evidence says about outcomes with frozen versus fresh embryos.
What Is Embryo Freezing?
Embryo freezing is the process of preserving embryos — created through IVF — at a specific stage of development, in a state in which all biological processes are halted, for potential use in a future transfer cycle.
The technology used for embryo freezing in modern IVF laboratories is vitrification — a rapid freezing process that distinguishes current practice from the slower freezing methods used in earlier decades of IVF. In vitrification, the embryo is treated with cryoprotective agents — specialized compounds that replace the water within the embryo's cells — and then plunged into liquid nitrogen at minus 196 degrees Celsius. The extreme speed of this cooling process prevents the formation of ice crystals, which in slower freezing methods caused physical damage to the embryo's cellular structure.
The result of vitrification is an embryo preserved in a glass-like state — the word "vitrification" comes from the Latin for glass — in which biological time is effectively suspended. The embryo does not age. It does not metabolize. It does not change. It exists, completely preserved, until it is thawed and used.
The survival rate of embryos through the vitrification and warming process at a well-equipped laboratory is very high — typically 90 to 95 percent or above for good-quality blastocysts. The quality of embryos that survive warming is, for the large majority, comparable to their pre-freeze quality — a marked improvement over the outcomes achievable with older slow-freezing methods.
Embryos are most commonly frozen at the blastocyst stage — day five or six of development — because blastocysts have the highest implantation potential and because selecting for blastocyst stage naturally eliminates embryos that were not developmentally competent to progress to this stage. Embryos can also be frozen at earlier stages — day two or three — when blastocyst development is not reliable for a specific patient, though blastocyst-stage freezing is the current standard in well-equipped IVF laboratories.
Why Are Embryos Frozen? The Clinical Reasons
Embryo freezing occurs in several distinct clinical contexts, each with its own rationale. Understanding these contexts helps explain why embryo freezing has become such a central element of modern IVF practice.
Surplus embryos from a stimulation cycle. The most common reason embryos are frozen is simply that a stimulation cycle produces more good-quality blastocysts than are transferred in the initial fresh cycle. A woman who produces six blastocysts and transfers one fresh has five embryos available for future frozen transfers. These embryos represent the reproductive potential of that stimulation cycle — additional opportunities for pregnancy without repeating the full stimulation process.
The freeze-all strategy. In some clinical situations, the decision is made not to perform a fresh embryo transfer at all — to freeze all embryos produced in a stimulation cycle and perform a transfer only in a subsequent cycle. This strategy — the freeze-all approach — is used in specific circumstances where a fresh transfer in the stimulation cycle is considered suboptimal.
The most important of these circumstances is elevated progesterone at the time of trigger or during the late stimulation phase. When progesterone rises prematurely during stimulation — a phenomenon that occurs in some patients, particularly those with high ovarian reserve — it can alter the endometrial environment in ways that reduce receptivity in the fresh cycle. Freezing all embryos and transferring in a subsequent cycle, when the endometrial preparation is not affected by the hormonal changes of stimulation, improves outcomes in these patients.
The freeze-all strategy is also used routinely in patients at high risk of ovarian hyperstimulation syndrome — particularly women with PCOS and very high AMH levels, in whom the hCG of early pregnancy would compound the risk of severe OHSS if a fresh transfer were performed. By freezing all embryos and deferring transfer to a natural or artificially prepared subsequent cycle, the risk of OHSS is essentially eliminated.
PGT-A testing. When preimplantation genetic testing is performed — to screen embryos for chromosomal abnormalities before transfer — all embryos are necessarily frozen while the genetic results are awaited. PGT-A results typically take one to two weeks to return, making same-cycle fresh transfer impossible. Frozen embryo transfer in a subsequent cycle, using only the embryos confirmed as chromosomally normal, follows the test results.
Patient convenience and clinical timing. In some cases, the endometrium on the day of planned transfer in a fresh cycle is found to be suboptimal — either thin, or with a pattern suggesting poor receptivity. Rather than proceeding with a transfer into an inadequately prepared uterus, the embryos are frozen and transfer is deferred to a cycle in which the endometrium can be more optimally prepared.
What Is a Frozen Embryo Transfer (FET) Cycle?
A frozen embryo transfer cycle is the clinical process by which a previously frozen embryo is thawed and transferred to the uterus in a cycle separate from the stimulation cycle in which it was created. Understanding the FET cycle requires understanding how it differs from the fresh transfer cycle and what its specific components involve.
The most important difference between a fresh IVF cycle and a FET cycle is that the FET cycle does not involve ovarian stimulation or egg retrieval. The ovaries play no role in a standard FET cycle. The eggs have already been retrieved, fertilized, and developed into embryos — that process is complete. What the FET cycle adds is the preparation of the uterus to receive the frozen embryo.
This preparation can take two forms — a natural cycle FET or an artificial (hormonally prepared) cycle FET — and the choice between them is individualized to the patient's specific clinical situation.
Natural Cycle FET
In a natural cycle FET, the woman's own hormonal cycle drives endometrial development. Ovulation is monitored through ultrasound and blood tests — measuring LH surge and follicle development — and the embryo transfer is timed to occur a specific number of days after natural ovulation, corresponding to the developmental stage of the embryo being transferred.
Natural cycle FET is appropriate for women who ovulate regularly and predictably — who have menstrual cycles of consistent length and who produce a well-timed LH surge. Its advantage is that the endometrial preparation is driven by the woman's own hormones, which some evidence suggests may produce an endometrial environment that is particularly well-matched to implantation. Its limitation is that the timing depends on the natural LH surge, which can vary slightly between cycles, making precise timing somewhat less controllable than in an artificially prepared cycle.
Artificial (Medicated) Cycle FET
In an artificially prepared FET cycle, estrogen — administered as tablets, patches, or vaginal suppositories — is given to build the endometrial lining from the start of the cycle, without relying on the woman's own hormonal cycle. When the endometrium has reached the appropriate thickness and pattern — assessed by ultrasound, typically after eight to twelve days of estrogen — progesterone is added to trigger the endometrial transition from the proliferative phase to the receptive phase. The embryo transfer is then timed to a specific number of days after progesterone initiation.
The artificial FET cycle offers precise timing control — the moment of progesterone start, and therefore the timing of the transfer, can be adjusted to the specific day that is clinically optimal. It is particularly appropriate for women with irregular cycles, for women who have had ERA testing identifying a displaced implantation window (where the progesterone start is adjusted to match the personalized window), and in any situation where precise control over transfer timing is clinically important.
The Transfer Procedure Itself
The embryo transfer procedure in a FET cycle is identical to the transfer procedure in a fresh IVF cycle — a simple, ten-minute procedure performed without anesthesia, in which a thin catheter passes through the cervix and deposits the embryo into the uterine cavity under ultrasound guidance.
Before the transfer, the frozen embryo is thawed — a process that takes approximately two hours on the day of transfer — and assessed by the embryologist for survival and quality. Most vitrified blastocysts survive thawing with intact or minimally affected morphology. The couple is informed of the thaw result before the transfer proceeds.
After the transfer, progesterone supplementation continues through the fourteen-day wait until the pregnancy blood test.
What Are the Success Rates of FET Compared to Fresh Transfer?
This is one of the most clinically important questions in modern IVF practice — and the answer has shifted substantially over the past decade as vitrification technology has matured and as the evidence base for freeze-all strategies has grown.
In the early years of embryo freezing, when slow-cooling rather than vitrification was the standard technology, fresh embryo transfer consistently outperformed frozen embryo transfer in terms of implantation rates and live birth rates. The freezing process, though useful for preserving surplus embryos, was not as reliable as it is today, and embryo survival and quality after thawing were noticeably lower than at the time of freezing.
With the widespread adoption of vitrification — which produces embryo survival rates of 90 to 95 percent or above — this picture has changed. Multiple well-designed studies have now shown that frozen embryo transfer using vitrified blastocysts produces implantation and live birth rates that are comparable to, and in some specific patient populations higher than, those achievable with fresh transfer.
The populations in which FET consistently outperforms fresh transfer include women with premature progesterone elevation during stimulation — where the endometrium in a fresh cycle is hormonally compromised — and women at risk of OHSS, in whom deferring transfer to a frozen cycle completely eliminates the ovarian hyperstimulation risk while delivering equivalent or better reproductive outcomes.
In the broader IVF population, fresh and frozen transfers produce comparable outcomes in well-managed cycles at well-equipped laboratories. The clinical advantage of freezing all embryos and deferring all transfers is not universal — for women without the specific risk factors described above, a fresh transfer in an adequately prepared uterus is a reasonable first approach — but the availability of high-quality frozen transfer as a fallback, or as a primary strategy in appropriate cases, is one of the most important tools in modern IVF practice.
The Clinical Advantage of Frozen Embryos for Multiple Attempts
Beyond the comparison of fresh versus frozen in a single cycle, embryo freezing offers a significant strategic advantage in the broader context of cumulative IVF treatment: it dramatically increases the reproductive yield of a single stimulation cycle.
A stimulation cycle that produces six blastocysts can, through a combination of a fresh transfer and subsequent frozen transfers, provide six separate opportunities for pregnancy from a single stimulation. Without freezing, the reproductive potential of the five untransferred embryos is lost entirely. With freezing, each embryo represents a future opportunity — at a fraction of the cost and physical demand of a new stimulation cycle.
This cumulative reproductive potential is one of the most compelling arguments for the freeze-all strategy when a stimulation cycle produces multiple good-quality blastocysts. Rather than committing the best embryo to a fresh transfer and discarding the rest, freezing all embryos preserves the full yield of the cycle — giving the couple multiple opportunities while exposing the woman to ovarian stimulation only once.
For couples who have been told that IVF is expensive or that they can afford only a limited number of attempts, the strategic value of a freeze-all approach that maximizes the reproductive potential of each stimulation cycle is directly relevant to their situation.
What Metro IVF's Approach to Embryo Freezing and FET Looks Like
At Metro IVF in Ambikapur, the decision about whether to proceed with a fresh transfer or to freeze all embryos — and the design of any subsequent FET cycle — is individualized to each patient's specific clinical picture.
The stimulation cycle is monitored for the specific factors that indicate a freeze-all approach — progesterone levels, ovarian response, and any clinical finding that suggests the endometrial environment in the fresh cycle may be suboptimal. When a freeze-all is indicated, the decision is made before the retrieval or immediately after, and the couple is given a clear explanation of why deferring to a frozen transfer cycle serves their clinical interests.
For FET cycles, the choice between natural and artificial cycle preparation is discussed based on the patient's cycle regularity, the availability of ERA testing results if applicable, and any additional factors relevant to endometrial preparation. The transfer timing is confirmed by monitoring ultrasound and, where ERA has been performed, personalized to the patient's individual implantation window.
The embryology team at Metro IVF maintains the vitrification and warming protocols that deliver the high embryo survival rates that modern frozen transfer success requires. The laboratory quality that underlies successful FET — precise temperature control, optimal cryoprotective agent protocols, experienced embryologist judgment — is a non-negotiable clinical standard at the clinic.
Your Next Step
If you are considering IVF and want to understand how embryo freezing and frozen embryo transfer fit into your treatment plan — or if you have frozen embryos from a previous cycle and want to discuss the optimal approach to a FET cycle — a consultation with Dr. Ashish Soni at Metro IVF in Ambikapur is the right starting point.
The decisions around freezing strategy, FET protocol design, and transfer timing are among the most clinically significant decisions in IVF — and they deserve to be made with the most complete and individualized clinical information available.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
Every frozen embryo is a future opportunity. Make sure yours are in the best possible hands. Book your consultation with Dr. Ashish Soni at Metro IVF today.